Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CCNC | P24863 | 1/20 | 0.30 |
| ▸ | CDK8 | P49336 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26415947 | 0.97 | KDM4E (0.33) | SIRT2SIRT1 | |
| SCHEMBL26415942 | 0.97 | KDM4E (0.33) | SIRT2SIRT1 | |
| SCHEMBL26416010 | 0.93 | KDM4E (0.33) | SIRT2SIRT1MAPT | |
| SCHEMBL26416005 | 0.92 | KDM4E (0.31) | — | |
| SCHEMBL24151956 | 0.92 | SMN1; SMN2 (0.34) | SIRT2SIRT1TSHRLMNASMN1; SMN2 | |
| SCHEMBL22893713 | 0.90 | SMN1; SMN2 (0.33) | SIRT2SIRT1TSHRLMNASMN1; SMN2 | |
| SCHEMBL26416879 | 0.90 | KDM4E (0.30) | SMN1; SMN2KMT2A | |
| SCHEMBL26416925 | 0.90 | KDM4E (0.32) | MAPT | |
| SCHEMBL24154747 | 0.90 | PLA2G2A (0.34) | SIRT2SIRT1TSHRLMNASMN1; SMN2 | |
| SCHEMBL25051170 | 0.89 | TSHR (0.33) | SIRT2SIRT1TSHRLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | CRY1, ORC3, ODC1 | SIRT2 2048/4885SIRT1 1465/4885TSHR 4641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.